Cullinan Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $980K | Hold |
|
|||||
|
2025
Q2 | $985K | Hold |
|
|||||
|
2025
Q1 | $913K | Hold |
|
|||||
|
2024
Q4 | $933K | Sell |
|
|||||
|
2024
Q3 | $973K | Hold |
|
|||||
|
2024
Q2 | $1.28M | Hold |
|
|||||
|
2024
Q1 | $1.33M | Buy |
|
|||||
|
2023
Q4 | $977K | Hold |
|
|||||
|
2023
Q3 | $888K | Hold |
|
|||||
|
2023
Q2 | $1.21M | Hold |
|
|||||
|
2023
Q1 | $1.06M | Hold |
|
|||||
|
2022
Q4 | $956K | Hold |
|
|||||
|
2022
Q3 | $1.06M | Hold |
|
|||||
|
2022
Q2 | $1.22M | Buy |
|
|||||
|
2022
Q1 | $766K | Hold |
|
|||||
|
2021
Q4 | $844K | Hold |
|
|||||
|
2021
Q3 | $737K | Hold |
|
|||||
|
2021
Q2 | $674K | Buy |
|
|||||
|
2021
Q1 | $435K | Hold |
|
|||||
|
2020
Q4 | $474K | Buy |
|